Evidence map›Paper›PMID 27529282›Full record

ReviewCells2016

Skeletal Muscle Laminopathies: A Review of Clinical and Molecular Features.

Lorenzo Maggi, Nicola Carboni, Pia Bernasconi

Open access · goldAbstract readReview
In one paragraph

Review in Cells, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 99 citations in OpenAlex.

  1. Article
  2. Review
  3. Twenty-Five-Year Follow-Up of the MDDC1 Family: ACirculation. Genomic and precision medicine · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Journal of neurology, neurosurgery, and psychiatry · 2025
    Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Genotype‒phenotype correlation in recessive DNAJB4 myopathy.Acta neuropathologica communications · 2024
    Article
  14. Article
  15. Review
  16. Annals of the Child Neurology Society · 2024
    Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Lorenzo MaggiNeurology IV-Neuroimmunology and Neuromuscular Diseases Unit, Fondazione Istituto Neurologico Carlo Besta, 20133 Milan, Italy. lorenzo.maggi@istituto-besta.it.
Nicola CarboniNeurology Department, Hospital San Francesco of Nuoro, 08100 Nuoro, Italy. nikola.carboni@tiscali.it.
Pia BernasconiNeurology IV-Neuroimmunology and Neuromuscular Diseases Unit, Fondazione Istituto Neurologico Carlo Besta, 20133 Milan, Italy. pia.bernasconi@istituto-besta.it.
Fondazione IRCCS Istituto Neurologico Carlo Besta · ITAssociazione Istituzione Libera Università Nuorese · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

LMNA-related disorders are caused by mutations in the LMNA gene, which encodes for the nuclear envelope proteins, lamin A and C, via alternative splicing. Laminopathies are associated with a wide range of disease phenotypes, including neuromuscular, cardiac, metabolic disorders and premature aging syndromes. The most frequent diseases associated with mutations in the LMNA gene are characterized by skeletal and cardiac muscle involvement. This review will focus on genetics and clinical features of laminopathies affecting primarily skeletal muscle. Although only symptomatic treatment is available for these patients, many achievements have been made in clarifying the pathogenesis and improving the management of these diseases.

Indexed as

arrhythmiacardiomyopathycongenital muscular dystrophyEmery-Dreifuss muscular dystrophylaminopathieslimb-girdle muscular dystrophyLMNA gene

Identifiers

PMID27529282
PMCPMC5040975
OpenAlexW2507705118

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.